Outcomes after angiography with sodium bicarbonate and acetylcysteine

New England Journal of Medicine

Volumn 378, Issue 7, 2018, Pages 603-614

  Weisbord, S D ^a   Gallagher, M ^b,c   Jneid, H ^e   Garcia, S ^f   Cass, A ^c,d   Thwin, S S ^g   Conner, T A ^j   Chertow, G M ^k   Bhatt, D L ^h,i   Shunk, K ^l   Parikh, C R ^m   McFalls, E O ^f   Brophy, M ^g   Ferguson, R ^g   Wu, H ^g   Androsenko, M ^g   Myles, J ^g   Kaufman, J ^g   Palevsky, P M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g Massachusetts Veterans Epidemiology and Research Information Center   (United States)

^h Interventional Cardiology Section   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j VA Cooperative Studies Program Clinical Research Pharmacy   (United States)

^k STANFORD UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m YALE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; CONTRAST MEDIUM; PLACEBO; SODIUM CHLORIDE; CREATININE;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; AGED; ANGIOGRAPHY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FEMALE; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE; BLOOD; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RISK FACTOR; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ADMINISTRATION, ORAL; AGED; ANGIOGRAPHY; CONTRAST MEDIA; CREATININE; DOUBLE-BLIND METHOD; FEMALE; FLUID THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM BICARBONATE; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 85042362344     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1710933     Document Type: Article

References (29)

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill W W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75.
2. Subramanian S, Tumlin J, Bapat B, Zyczynski T. Economic burden of contrast-induced nephropathy: implications for prevention strategies. J Med Econ 2007;10:119-34.
3. James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a longterm decline in kidney function. Kidney Int 2010;78:803-9.
4. Bahrainwala JZ, Leonberg-Yoo AK, Rudnick MR. Use of radiocontrast agents in CKD and ESRD. Semin Dial 2017;30:290-304.
5. Zapata-Chica CA, Bello Marquez D, Serna-Higuita LM, Nieto-Ríos JF, Casas-Arroyave FD, Donado-Gómez JH. Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy: a systematic review and meta-analysis. Colomb Med (Cali) 2015;46:90-103.
6. Zhang B, Liang L, Chen W, Liang C, Zhang S. The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis. BMJ Open 2015;5(3):e006989.
7. Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and metaanalysis. Ann Intern Med 2016;164:406-16.
8. Xu R, Tao A, Bai Y, Deng Y, Chen G. Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5(9):e003968.
9. Kang X, Hu DY, Li CB, Ai ZS, Peng A. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and metaanalysis. Ren Fail 2015;37:297-303.
10. Loomba RS, Shah PH, Aggarwal S, Arora RR. Role of N-acetylcysteine to prevent contrast-induced nephropathy: a meta-analysis. Am J Ther 2016;23:e172-e183.
11. Zhao SJ, Zhong ZS, Qi GX, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol 2016;221:251-9.
12. Weisbord SD, Gallagher M, Kaufman J, et al. Prevention of contrast-induced AKI: a review of published trials and the design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) trial. Clin J Am Soc Nephrol 2013;8:1618-31.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
14. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton, FL: Chapman and Hall/CRC, 2000.
15. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34.
16. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
17. Weisbord SD, Mor MK, Resnick AL, et al. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 2008;168:1325-32.
18. Chertow GM, Palevsky PM, Greene T. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. Clin J Am Soc Nephrol 2006;1:1124-7.
19. ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrastinduced nephropathy Trial (ACT). Circulation 2011;124:1250-9.
20. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996;275:1489-94.
21. Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 2013;61:649-72.
22. Masuda M, Yamada T, Mine T, et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007;100:781-6.
23. Hoste EA, De Waele JJ, Gevaert SA, Uchino S, Kellum JA. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 2010;25:747-58.
24. Miner SE, Dzavik V, Nguyen-Ho P, et al. N-acetylcysteine reduces contrastassociated nephropathy but not clinical events during long-term follow-up. Am Heart J 2004;148:690-5.
25. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial: the Iohexol Cooperative Study. Kidney Int 1995;47:254-61.
26. Pakfetrat M, Nikoo MH, Malekmakan L, et al. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. Int Urol Nephrol 2009;41:629-34.
27. Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 2007;49:1283-8.
28. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8.
29. McCullough PA, Adam A, Becker CR, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006;98:6A: 27K-36K.